High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells
- 1 November 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 91 (3) , 664-667
- https://doi.org/10.1111/j.1365-2141.1995.tb05365.x
Abstract
Summary. We have studied the retinoblastoma (RB-1) susceptibility gene status and pRB expression in 22 human myeloma cell lines (HMCL) and in 10 patients with advanced multiple myeloma (MM). Deletions of the RB-1 gene were observed in 81% (17/21) of the informative HMCL, regardless of their paracrine or autocrine interleukin-6 (IL-6) status. Among the deleted HMCL, only one (U266) had a biallelic deletion and lacked pRB expression. Monoallelic deletions had no consequence on the RB-1 gene activation and pRB expression. One patient of 10 presented the same biallelic deletion as U266 and six of 10 had monoallelic deletions. We conclude that monoallelic deletions of the RB-1 gene are frequent in HMCL and MM patients but have no consequence on gene activation and pRB expression.Keywords
This publication has 5 references indexed in Scilit:
- Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myelomaBlood, 1994
- Decreased retinoblastoma protein expression in acute myeloblastic leukaemia is associated with the autonomous proliferation of clonogenic blastsBritish Journal of Haematology, 1994
- IFN-alpha induces autocrine production of IL-6 in myeloma cell lines.The Journal of Immunology, 1991
- Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.Proceedings of the National Academy of Sciences, 1991
- Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.Journal of Clinical Investigation, 1991